XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 1 Months Ended 2 Months Ended 3 Months Ended 5 Months Ended 6 Months Ended
Jan. 26, 2022
Mar. 31, 2022
Jun. 30, 2022
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2022
Jun. 30, 2022
Jun. 30, 2021
Jan. 27, 2022
Dec. 31, 2021
Cash flows from Operating Activities:                    
Net income (loss) $ (37,061) $ (43,378) $ (33,844) $ 11,772 $ 6,743 $ (77,222)   $ 18,515    
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:                    
Depreciation and amortization 1,000   32,094 3,112   54,022   6,801    
Share-based compensation 23,705         57,470   224    
Amortization of debt issuance costs 0         2,226   1,131    
Noncash lease expense 115         694   0    
Change in fair value of contingent consideration and CEO equity profit interest (9)         (27)   4,331    
Change in fair value of warrants 0   4,139     9,622   0    
Deferred tax benefits (816)         (22,746)   (603)    
Other 0         661   0    
Changes in operating assets and liabilities                    
Accounts receivable 11,118         (8,136)   (8,306)    
Due from related party 0         0   0    
Prepaids and other assets 1,069         (2,002)   (1,864)    
Accounts payable (67,600)         6,535   8,568    
Accrued expenses and other liabilities 57,488         (11,225)   (1,978)    
Protected.net incentive plan liability 0         5,694   0    
Deferred revenue 311         7,211   494    
Other long-term liabilities 77         (31,080)   0    
Net cash (used in) operating activities (10,603)         (8,303)   27,313    
Cash flows from Investing Activities:                    
Purchases of property and equipment 0         (2,310)   0    
Capitalized software development costs (441)         (3,497)   (3,233)    
Acquisition of businesses, net of cash acquired 0         (444,074)   0    
Net cash used in investing activities (441)         (449,881)   (3,233)    
Cash flows from Financing Activities:                    
Proceeds from term loan and line of credit 0         449,000   0    
Repayment of term loan 0         (177,488)   (8,136)    
Member capital contributions 0         0   150    
Payments on contingent consideration from purchase of companies 0         0   (6,715)    
Payments for financing costs 0         (24,845)   0    
Payments for earnouts 0         (1,715)   0    
Redemptions of Class A common stock 0         (510,469)   0    
Proceeds from warrant exercises 0         5,027 $ 5,028 0    
Cash received from the Backstop 0         246,484   0    
Related party loan 0         0        
Related party loan               (1,500)    
Distributions to members 0         (1,501)   (2,691)    
Net cash used in financing activities 0         (15,507)   (18,892)    
Effect of exchange rate changes in cash, cash equivalent and restricted cash (19)         604   366    
Net increase (decrease) in cash, cash equivalents and restricted cash (11,063)         (473,087)   5,554    
Cash and cash equivalents and restricted cash, beginning of the period 48,639 $ 37,576     $ 29,013 37,576 48,639 29,013    
Cash and cash equivalents and restricted cash, end of the period 37,576   44,466 34,567   44,466 44,466 34,567    
Reconciliation of cash, cash equivalents and restricted cash to the Consolidated Balance Sheets:                    
Cash and cash equivalents 36,833   37,442 34,567   37,442 37,442 34,567   $ 47,896
Restricted cash 743   7,024 0   7,024 7,024 0    
Total cash, cash equivalents and restricted cash 37,576   $ 44,466 $ 34,567   44,466 $ 44,466 34,567 $ 517,553 $ 48,639
Supplemental cash flow information:                    
Cash paid for operating lease liabilities 175         563   0    
ROU assets obtained in exchange for operating lease liabilities 7,987         2,064   0    
Equity issuance to settle intercompany loan 941         0   0    
Deferred consideration for acquisition $ 0         $ 7,059   $ 0